Register Now
Why register?
 The leading web portal for pharmacy resources, news, education and careers September 27, 2016
Pharmacy Choice - Pharmacy News - September 27, 2016

Pharmacy News

Today's Pharmaceutical and Pharmacy News
Daily News Topic:

FDA News
9/27/16 - Asterias Biotherapeutics Announces Dosing of First Patient in New SCiSTAR Clinical Trial Cohort Testing AST-OPC1 in an Expanded Cervical Spinal Cord Injury Patient Population
--Asterias Biotherapeutics, Inc., a biotechnology company pioneering the field of regenerative medicine, today announced that the first patient with incomplete AIS-B cervical spinal cord injury was successfully dosed with 10 million cells of AST-OPC1 in the SCiSTAR clinical trial at Shepherd Center in Atlanta. The company recently received FDA clea
9/27/16 - FDA Approves STELARA (Ustekinumab) for Treatment of Adults With Moderately to Severely Active Crohn's Disease
Release date- 26092016- Horsham, Pa- Janssen Biotech, Inc., announced today that the U.S. Food and Drug Administration has approved STELARA for the treatment of moderately to severely active Crohn's disease in adults who have failed or were intolerant to treatment with immunomodulators or corticosteroids but never failed treatment with a tumor necr
9/27/16 - Medtronic's StealthStation Cranial Software Receives FDA Clearance as an Aid for Deep Brain Stimulation Lead Placement
Release date- 26092016- DUBLIN and SAN DIEGO- Medtronic plc today announced U.S. Food and Drug Administration clearance of StealthStation Cranial Software as an aid for deep brain stimulation lead placement. The software is fully integrated with Medtronic's latest O-arm Imaging System, providing clinicians with a complete procedural solution for th
9/27/16 - U.S. FDA Approves Labeling Update of REXULTI(brexpiprazole) for Maintenance Treatment of Schizophrenia in Patients in the U.S.
Release date- 26092016- Otsuka Pharmaceutical Development& Commercialization, Inc. and H. Lundbeck A/S announced today that the U.S. Food and Drug Administration approved the labeling update of REXULTI to reflect clinical data for maintenance treatment of schizophrenia in patients in the U.S.. The approval was based on results from a long-term rand
9/26/16 - AbbVie Announces Submission of a Supplemental New Drug Application for Ibrutinib (IMBRUVICA®) for Treatment of Marginal Zone Lymphoma
--AbbVie, a global biopharmaceutical company, today announced that it submitted a supplemental New Drug Application to the U.S. Food and Drug Administration for ibrutinib to treat patients with marginal zone lymphoma. IMBRUVICA is jointly developed and commercialized by Pharmacyclics LLC, an AbbVie company and Janssen Biotech, Inc.. "We continue t
9/26/16 - Allergan Receives FDA Approval to Market Natrelle Inspira Breast Implants
Allergan plc announces it has received approval from the US Food and Drug Administration (FDA) to market Natrelle Inspira Cohesive breast implants, the latest entry in the â??gummyâ?? category of implants.

Chain Drug Review
Chain Drug Review Magazine Chain Drug Review, established in 1978 and published 21 times a year, is recognized as the premier news publication serving the entire chain drug store industry.
Featured Article from Chain Drug Review:
AWP suit settlement appealed
The National Association of Chain Drug Stores has appealed a U.S. District Court’s approval of settlements in the First DataBank Inc. and Medi-Span Inc. lawsuit. »read more

Pharmacy News Index
  Drug Delivery Systems
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry


Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
Pharmacy Spanish
This lesson is supported by:
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...

Websites »
Copyright © 2009 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement